http://www.onemedplace.com/blog/wp-content/uploads/2010/05/medicines.jpg
The company's lead product is Restanza (cethromycin), a novel once-a-day antibiotic for the treatment of life-threatening bacterial infections and bioterror pathogens.
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2010/04/pills.jpg
Advanced Life Sciences (OTC BB: ADLS) took two steps this week toward advancing its lead drug candidate, Restanza.
View Article
More Pages to Explore .....
